Table 1.

Characteristic of patients included in the study.

Nr	Gender	Age at biopsy	rs815 (IFNL4)	HCV genotype	Log₁₀ (viral load)	Metavir	FACS	Immunohistochemistry
1	f	64	ΔG/ΔG	1b	5.44	A2/F1	X	X
2	m	58	ΔG/ΔG	3a	5.47	A3/F3	X	X
3	m	24	ΔG/ΔG	1	4.81	A1/F0	X	X
4	m	49	ΔG/ΔG	4	6.50	A1/F1		X
5	m	61	ΔG/ΔG	1b	n.a	A2/F2		X
6	m	51	ΔG/ΔG	1b	5.75	A2/F4		X
7	m	40	ΔG/ΔG	3a	5.66	A1/F1		X
8	f	53	ΔG/ΔG	4a/c/d	5.90	A3/F3		X
9	m	48	ΔG/ΔG	4a/c/d	6.03	A2/F2		X
10	m	30	ΔG/ΔG	1a	5.03	A1/F1		X
11	m	24	ΔG/ΔG	1a	5.26	A1/F0		X
12	m	52	TT/ΔG	3a	6.69	A2/F2	X	X
13	m	56	TT/ΔG	3a	5.75	A3/F4	X	X
14	m	50	TT/ΔG	1a	6.92	A3/F2	X	X
15	f	37	TT/ΔG	1a	n.a	A1/F2	X	X
16	m	46	TT/ΔG	4a/c/d	5.06	A3/F4	X	X
17	m	45	TT/ΔG	1b	5.25	A1/F1	X	X
18	M	15	TT/ΔG	1a	5.44	A1/F1		X
19	f	47	TT/ΔG	1a	6.78	A2/F4		X
20	m	45	TT/ΔG	1a	6.21	A2/F2		X
21	m	42	TT/TT	3a	6.98	A2/F1	X	X
22	f	52	TT/TT	4	n.a	A2/F2	X	X
23	m	77	TT/TT	1b	5.92	A2/F3	X	X
24	m	61	TT/TT	1a	n.a	A2/F1	X	X
25	m	43	TT/TT	1	5.97	A1/F1		X
26	f	45	TT/TT	3a	5.06	A1/F1		X
27	f	45	TT/TT	1b	6.38	A2/F1		X
28	m	53	TT/TT	n.a	6.47	A2/F2		X
29	f	52	TT/TT	1a	6.09	A2/F1		X
30	m	36	TT/TT	3a	5.90	A1/F1		X
31	m	43	TT/TT	1a	3.60	A1/F1		X
32	m	39	TT/TT	3a	6.41	A1/F1		X
33	f	41	TT/TT	1b	6.44	A2/F3		X
34	m	50	TT/TT	3a	6.52	A2/F1		X
35	m	53	TT/TT	3a	6.52	A3/F4		X
36	m	56	TT/TT	1a	6.80	A3/F3		X
37	m	45	TT/TT	3a	5.87	A2/F4		X
38	f	37	TT/TT	1a	6.19	A2/F3		X
39	m	53	TT/TT	4	6.12	A1/F1		X